{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:39:50Z","timestamp":1786995590886,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedhc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Health Care"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.pedhc.2018.10.002","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T21:04:59Z","timestamp":1546981499000},"page":"e1-e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Somnolence-Producing Agents: A 5-Year Study of Prescribing for Medicaid-Insured Children With Attention Deficit Hyperactivity Disorder"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-3538","authenticated-orcid":false,"given":"Tracy","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri M.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Panther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0804-5273","authenticated-orcid":false,"given":"Tamara","family":"Odom-Maryon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenn","family":"Daratha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedhc.2018.10.002_bib0001","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1542\/peds.2011-2654","article-title":"ADHD: Clinical practice guidelines for the diagnosis, evaluation, and treatment of attention-hyperactivity disorder in children and adolescents","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0045","series-title":"Prescribing information for Seroquel (quetiapine fumarate)","year":"2015"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11920-016-0687-0","article-title":"Insomnia: The sleeping giant of pediatric public health","volume":"18","author":"Badin","year":"2016","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0003","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/bja\/55.4.275","article-title":"Lorazapam in children: A double-blind trial comparing lorazapam, diazepam, trimeprazine and placebo","volume":"55","author":"Burtles","year":"1983","journal-title":"British Journal of Anesthesia"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/apa.13472","article-title":"Children with developmental dyslexia showed greater sleep disturbances than controls, including problems initiating and maintaining sleep","volume":"105","author":"Carotenuto","year":"2016","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0006","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/j.sleep.2017.11.162","article-title":"Long term effects of methylphenidate on the sleep problems of children with attention-deficit\/hyperactivity disorder","volume":"40(Supplement 1)","author":"Chen","year":"2017","journal-title":"Sleep Medicine"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0007","series-title":"Prescribing information for Kapvay (clonidine hydrochloride)","year":"2015"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0008","unstructured":"Controlled Substances Act, 21 C.F.R. \u00a7 1308.12 Schedule II (U.S. Government Publishing Office, 2018)."},{"key":"10.1016\/j.pedhc.2018.10.002_bib0009","first-page":"894","article-title":"Sleep in children with attention-deficit\/hyperactivity disorder: Meta-analysis of subjective and objective studies","volume":"48","author":"Cortese","year":"2009","journal-title":"Journal of American Academy of Child Adolescent Psychiatry"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0010","series-title":"Prescribing information for Strattera (atomoxetine hydrochloride)","year":"2011"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/archdischild-2013-304446","article-title":"Antihistamine use in children","volume":"100","author":"Fitzsimons","year":"2015","journal-title":"Archives of Disease in Childhood-Education and Practice"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0012","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/dom.12931","article-title":"Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data","volume":"19","author":"Flory","year":"2017","journal-title":"Diabetes Obesity Metabolism"},{"issue":"6","key":"10.1016\/j.pedhc.2018.10.002_bib0013","doi-asserted-by":"crossref","first-page":"00095","DOI":"10.15406\/jpnc.2015.02.00095","article-title":"An evidence-based guideline for the pre-operative sedation of children","volume":"2","author":"Fradkin","year":"2015","journal-title":"Journal of Pediatric Neonatal Care"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0047","series-title":"Labeling information for Klonopin (clonazepam)","year":"2016"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/pds.3538","article-title":"Characteristics and trends of low\u2010dose quetiapine use in two western state Medicaid programs","volume":"23","author":"Hartung","year":"2014","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"7\u20138","key":"10.1016\/j.pedhc.2018.10.002_bib0015","first-page":"24","article-title":"Trazodone for insomnia: A systematic review","volume":"14","author":"Jaffer","year":"2017","journal-title":"Innovations in Clinical Neuroscience"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0016","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1542\/peds.2007-3308","article-title":"Sleep hygiene for children with neurodevelopmental disabilities","volume":"122","author":"Jan","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0017","author":"Ketchum"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0018","series-title":"Lorazapam: Pediatric drug information","year":"2018"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004630-199903000-00031","article-title":"Lorazepam given the night before surgery reduces preoperative anxiety in children undergoing reconstructive burn surgery","volume":"20","author":"McCall","year":"1999","journal-title":"Journal of Burn Care Rehabilitation"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1542\/peds.111.3.554","article-title":"Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit\/hyperactivity disorder","volume":"111","author":"O'Brien","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0021","series-title":"Oregon Medicaid Pharmaceutical Services Prior Authorization Criteria","year":"2016"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0022","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pop.2008.06.003","article-title":"Classification and epidemiology of childhood sleep disorders","volume":"35","author":"Owens","year":"2008","journal-title":"Primary Care"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0023","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.sleep.2009.11.015","article-title":"Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey","volume":"11","author":"Owens","year":"2010","journal-title":"Sleep Medicine"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0024","first-page":"423","article-title":"Off-label prescribing trends for ADHD medications for young and very young children on Medicaid","volume":"22","author":"Panther","year":"2017","journal-title":"Journal of Pediatric Pharmacologic Therapy"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0025","series-title":"Prescribing information for Vistaril (hydrozyzine pamoate)","year":"2014"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0026","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1610384","article-title":"Trial of amitriptyline, topiramate, and placebo for pediatric migraine","volume":"376","author":"Powers","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0027","series-title":"Prescribing information for Desyrel (trazodone)","year":"2017"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0028","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1087054714554932","article-title":"Effect on primary sleep disorders when children with ADHD are administered guanfacine extended release","volume":"22","author":"Rugino","year":"2018","journal-title":"Journal of Attention Disorders"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0046","series-title":"Prescribing information for Ambien (zolpidem tartrate)","year":"2008"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine Clinical Practice Guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"Journal of Clinical Sleep Medicine"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0030","series-title":"Drug class update: Attention deficit hyperactivity disorder","author":"Servid","year":"2017"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0031","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaad.2015.06.048","article-title":"H1-antihistamines for chronic spontaneous urticaria: An abridged Cochrane Systematic Review","volume":"73","author":"Sharma","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0032","series-title":"Prescribing information for Intuniv (guanfacine hydrochloride)","year":"2013"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0033","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1087054713479663","article-title":"Sleep and circadian rhythmicity in adult ADHD and the effect of stimulants: A review of the current literature","volume":"21","author":"Snitselaar","year":"2017","journal-title":"Journal of Attention Disorders"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0034","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/spen.2001.29042","article-title":"Sleep-wake function in children with neurodevelopmental and psychiatric disorders","volume":"8","author":"Stores","year":"2001","journal-title":"Seminars in Pediatric Neurology"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archpedi.162.4.336","article-title":"Sleep problems in children with attention-deficit\/hyperactivity disorder: Prevalence and the effect on the child and family","volume":"162","author":"Sung","year":"2008","journal-title":"Archives of Pediatric Adolescent Medicine"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0036","series-title":"Pharmaceutical giant AstraZeneca to pay $520million for off-label drug marketing. Press Release Number: 10-487","year":"2010"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0037","series-title":"Food and Drug Administration Adverse Events Reporting System","year":"2018"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0039","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2869.2006.00491.x","article-title":"Sleep hygiene and actigraphically evaluated sleep characteristics in children with ADHD and chronic sleep onset insomnia","volume":"15","author":"van der Heijden","year":"2006","journal-title":"Journal of Sleep Research"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11414-018-9605-z","article-title":"Prescription drug use and cost trends among Medicaid-enrolled children with disruptive behavioral disorders","volume":"45","author":"Zhao","year":"2018","journal-title":"Journal of Behavioral Health Services & Research"},{"key":"10.1016\/j.pedhc.2018.10.002_bib0041","article-title":"Concomitant use of psychotropic medication with stimulants for the treatment of ADHD in children and adolescents: A retrospective insurance claims study in the United States","author":"Zhou","year":"2018","journal-title":"Journal of Attention Disorders. [Article in Press]"}],"container-title":["Journal of Pediatric Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524518304152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524518304152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:08:26Z","timestamp":1760195306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891524518304152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0891524518304152"],"URL":"https:\/\/doi.org\/10.1016\/j.pedhc.2018.10.002","relation":{},"ISSN":["0891-5245"],"issn-type":[{"value":"0891-5245","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somnolence-Producing Agents: A 5-Year Study of Prescribing for Medicaid-Insured Children With Attention Deficit Hyperactivity Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedhc.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}